Latest Breaking News On - Gilmartin group - Page 19 : comparemela.com

MaxCyte Signs Strategic Platform License with Be Biopharma

Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs.

United kingdomAnya bolshemChris welshMaher masoudDavid deuchlerBio bcmsRichard jamesPanmure gordonMary jane elliottEmma earl freddy crossleyRupert deardenDavid rawlingsSeattle children research instituteBristol myers squibbMaxcyte incLongwood fund

HeartSciences to Present at the LD Micro Invitational XIV Conference

Southlake, TX, April 02, 2024 Heart Test Laboratories, Inc. d/b/a HeartSciences , an artificial intelligence -powered medical technology company focused on transforming ECGs/EKGs to save.

Ecgs ekgsAndrew simpsonVivian cervantesHeart test laboratories incGilmartin groupExchange commissionSecurities exchangeCtest laboratoriesChief executive officer andrew simpsonTuesday aprilSofitel newSecurities actSecurities exchange actPrivate securities litigation reform actHeartscience annual reportHeartscience quarterly report

Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid

SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the

United statesMichael fanucchiTranscarotid neuroprotectionMarissa bychChas mckhannBrian petersonGilmartin groupVascular instituteRoad medicalTranscarotid neuroprotection systemNeuroprotection systemChief executive officerSilk roadTranscarotid artery revascularizationSilk road medical

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSteve williamsonJohn mckuneBrian johnstonPulmonx zephyrMehul joshiGilead sciences incPulmonx corporation nasdaqGilmartin groupPulmonx corporationMaster of business administrationPrior to phenomex incPhenomex incExchange commissionResmed incSecurities exchange

Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS

SUNNYVALE, Calif., April 02, 2024 Silk Road Medical, Inc. , a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE® Transcarotid.

United statesMichael fanucchiTranscarotid neuroprotectionBrian petersonChas mckhannMarissa bychGilmartin groupVascular instituteRoad medicalTranscarotid neuroprotection systemNeuroprotection systemChief executive officerSilk roadTranscarotid artery revascularizationSilk road medical